Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

Immunotherapy: Open Access : Citations & Metrics Report

Articles published in Immunotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Immunotherapy: Open Access has got h-index 9, which means every article in Immunotherapy: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Immunotherapy: Open Access.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015

Total published articles

17 32 30 32 11 4 5 15 30 7

Research, Review articles and Editorials

6 11 18 15 9 3 5 9 18 4

Research communications, Review communications, Editorial communications, Case reports and Commentary

7 29 12 11 1 0 0 6 11 2

Conference proceedings

0 0 0 0 0 0 0 36 45 0

Citations received as per Google Scholar, other indexing platforms and portals

79 86 180 247 248 44 48 52 18 8
Journal total citations count 1028
Journal impact factor 0.77
Journal 5 years impact factor 1.13
Journal cite score 1.32
Journal h-index 9
Journal h-index since 2019 7
Important citations (68)

Tao j, oscillations k,zhiqiang f, long s, haining z (2016) human insulin growth factor - 1 induction and polymeric protein glycan - 1 silence on human bone marrow stem cells structure of the impact chin j clinicians 10: 11

Tao j, ying w, zhi fz , chang qx, ning zh (2017) effects of human insulin-like growth factor-1 and polyprotease-1 silencing on microfilament structure of human bone marrow stem cells chin j clinicians 11: 1

Sharma r, harish r (2015)stem cell research therapy for neurodegenerative disorders- in what way to make it work research & reviews: journal of medical and health sciences 4:3.

Charlier e, relic b, deroyer c, malaise o, neuville s, et al.(2016) insights on molecular mechanisms of chondrocytes death in osteoarthritis. international journal of molecular sciences. 17: 2146.

Bertholee d, maring jg, van kuilenburg ab (2016) genotypes affecting the pharmacokinetics of anticancer drugs. clinical pharmacokinetics 19:1-21.

Sharma sk, bagshawe kd (2017)translating antibody directed enzyme prodrug therapy (adept) and prospects for combination. expert opinion on biological therapy 17: 1-3.

Sarrabayrouse g, pich c, teiti i, tilkin‐mariame af(2017). regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti‐melanoma immune response. international journal of cancer 140: 747-55.

Prasanthi d (2016) anticancer drugs used in treatment of curing cancer. rrjpts 4: 3

Top